Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Herbalife Ltd. (HLF)

NYSE - Nasdaq Real Time Price. Currency in USD
13.99+0.04 (+0.29%)
At close: 04:00PM EDT
13.99 0.00 (0.00%)
After hours: 06:06PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close13.95
Open14.09
Bid13.90 x 800
Ask14.30 x 1200
Day's Range13.92 - 14.21
52 Week Range11.14 - 22.73
Volume1,944,280
Avg. Volume1,606,841
Market Cap1.385B
Beta (5Y Monthly)1.19
PE Ratio (TTM)6.11
EPS (TTM)2.29
Earnings DateOct 30, 2023 - Nov 03, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateFeb 28, 2014
1y Target Est20.70
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
29% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HLF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Herbalife Ltd.
    Analyst Report: Herbalife Nutrition LtdHerbalife sells nutritional supplements, personal care and weight-management products worldwide. Herbalife products are sold in 94 countries, and over half of sales come from outside the Americas. HLF was incorporated in the Cayman Islands in 2002 as a holding company for Herbalife International, which was founded in 1980. The operating company is headquartered in Los Angeles. With a market cap of more than $1.7 billion, the stock is generally regarded as mid-cap growth.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
Advertisement
Advertisement